Circulation Research, Vol 67, 272-283, Copyright © 1990 by American Heart Association
ARTICLES |
SR Holmberg and AJ Williams
Department of Cardiac Medicine, National Heart & Lung Institute, London, UK.
We have studied the effects of clinically useful anthraquinones on the cardiac sarcoplasmic reticulum calcium-release channel. Micromolar concentrations of doxorubicin and other anthracyclines at the cytosolic face of the channel significantly and reversibly increase the open probability of single channels in artificial phospholipid bilayers. Lifetime analysis shows that anthracyclines and calcium are synergistic activators of the calcium-release channel. Radiolabeled ryanodine binding suggests that all the anthracyclines studied are equally potent as channel activators in vitro. Mitoxantrone, an anthracenedione derivative, variably increases channel open probability at low (1-10 microM) concentrations. Higher concentrations are associated with the appearance of channel currents with lower amplitudes than the fully open state, and normal openings are reduced in frequency. At these concentrations, the interaction of mitoxantrone with the channel reduces the level of ryanodine binding. Abnormal function of the cardiac calcium-release channel will alter calcium handling within the myocyte and may be the basis for anthraquinone-related cardiotoxicity.
This article has been cited by other articles:
![]() |
J Butany, E Ahn, and A Luk Drug-related cardiac pathology J. Clin. Pathol., December 1, 2009; 62(12): 1074 - 1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Weiss and W. Kang P-Glycoprotein Inhibitors Enhance Saturable Uptake of Idarubicin in Rat Heart: Pharmacokinetic/Pharmacodynamic Modeling J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 688 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-X. Wang, X.-B. Zhou, and M. Korth Effects of Mitoxantrone on Excitation-Contraction Coupling in Guinea Pig Ventricular Myocytes J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 501 - 508. [Abstract] [Full Text] |
||||
![]() |
W. Feng, G. Liu, R. Xia, J. J. Abramson, and I. N. Pessah Site-Selective Modification of Hyperreactive Cysteines of Ryanodine Receptor Complex by Quinones Mol. Pharmacol., May 1, 1999; 55(5): 821 - 831. [Abstract] [Full Text] |
||||
![]() |
B. Tanna, W. Welch, L. Ruest, J. L. Sutko, and A. J. Williams Interactions of a Reversible Ryanoid (21-Amino-9{alpha}-Hydroxy-Ryanodine) with Single Sheep Cardiac Ryanodine Receptor Channels J. Gen. Physiol., July 1, 1998; 112(1): 55 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zucchi and S. Ronca-Testoni The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States Pharmacol. Rev., March 1, 1997; 49(1): 1 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-X. Wang and M. Korth Effects of Doxorubicin on Excitation-Contraction Coupling in Guinea Pig Ventricular Myocardium Circ. Res., April 1, 1995; 76(4): 645 - 653. [Abstract] [Full Text] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1990 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |